Brazil · Delayed Price · Currency is BRL Raia Drogasil Statistics
Total Valuation
Raia Drogasil has a market cap or net worth of BRL 31.98 billion. The enterprise value is 39.81 billion.
| Market Cap | 31.98B |
| Enterprise Value | 39.81B |
Important Dates
The last earnings date was Tuesday, August 5, 2025.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | Jul 4, 2025 |
Share Statistics
Raia Drogasil has 1.71 billion shares outstanding. The number of shares has decreased by -32.28% in one year.
| Current Share Class | 1.71B |
| Shares Outstanding | 1.71B |
| Shares Change (YoY) | -32.28% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 20.85% |
| Owned by Institutions (%) | 49.71% |
| Float | 838.41M |
Valuation Ratios
The trailing PE ratio is 25.27 and the forward PE ratio is 23.78. Raia Drogasil's PEG ratio is 1.55.
| PE Ratio | 25.27 |
| Forward PE | 23.78 |
| PS Ratio | 0.78 |
| PB Ratio | 4.78 |
| P/TBV Ratio | 6.91 |
| P/FCF Ratio | 21.34 |
| P/OCF Ratio | 11.05 |
| PEG Ratio | 1.55 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.65, with an EV/FCF ratio of 26.56.
| EV / Earnings | 32.60 |
| EV / Sales | 0.97 |
| EV / EBITDA | 9.65 |
| EV / EBIT | 16.58 |
| EV / FCF | 26.56 |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 1.26.
| Current Ratio | 1.40 |
| Quick Ratio | 0.44 |
| Debt / Equity | 1.26 |
| Debt / EBITDA | 2.04 |
| Debt / FCF | 5.62 |
| Interest Coverage | 2.70 |
Financial Efficiency
Return on equity (ROE) is 19.19% and return on invested capital (ROIC) is 10.40%.
| Return on Equity (ROE) | 19.19% |
| Return on Assets (ROA) | 6.86% |
| Return on Invested Capital (ROIC) | 10.40% |
| Return on Capital Employed (ROCE) | 17.72% |
| Revenue Per Employee | 610,287 |
| Profits Per Employee | 18,196 |
| Employee Count | 64,758 |
| Asset Turnover | 1.87 |
| Inventory Turnover | 3.61 |
Taxes
In the past 12 months, Raia Drogasil has paid 84.83 million in taxes.
| Income Tax | 84.83M |
| Effective Tax Rate | 6.43% |
Stock Price Statistics
The stock price has decreased by -33.06% in the last 52 weeks. The beta is 0.08, so Raia Drogasil's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -33.06% |
| 50-Day Moving Average | 15.19 |
| 200-Day Moving Average | 18.91 |
| Relative Strength Index (RSI) | 76.72 |
| Average Volume (20 Days) | 12,750,305 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Raia Drogasil had revenue of BRL 40.96 billion and earned 1.22 billion in profits. Earnings per share was 0.74.
| Revenue | 40.96B |
| Gross Profit | 12.04B |
| Operating Income | 2.40B |
| Pretax Income | 1.32B |
| Net Income | 1.22B |
| EBITDA | 3.16B |
| EBIT | 2.40B |
| Earnings Per Share (EPS) | 0.74 |
Balance Sheet
The company has 605.30 million in cash and 8.42 billion in debt, giving a net cash position of -7.82 billion or -4.56 per share.
| Cash & Cash Equivalents | 605.30M |
| Total Debt | 8.42B |
| Net Cash | -7.82B |
| Net Cash Per Share | -4.56 |
| Equity (Book Value) | 6.69B |
| Book Value Per Share | 3.89 |
| Working Capital | 3.78B |
Cash Flow
In the last 12 months, operating cash flow was 2.89 billion and capital expenditures -1.39 billion, giving a free cash flow of 1.50 billion.
| Operating Cash Flow | 2.89B |
| Capital Expenditures | -1.39B |
| Free Cash Flow | 1.50B |
| FCF Per Share | 0.87 |
Margins
Gross margin is 29.40%, with operating and profit margins of 5.86% and 2.98%.
| Gross Margin | 29.40% |
| Operating Margin | 5.86% |
| Pretax Margin | 3.22% |
| Profit Margin | 2.98% |
| EBITDA Margin | 7.70% |
| EBIT Margin | 5.86% |
| FCF Margin | 3.66% |
Dividends & Yields
This stock pays an annual dividend of 0.41, which amounts to a dividend yield of 2.18%.
| Dividend Per Share | 0.41 |
| Dividend Yield | 2.18% |
| Dividend Growth (YoY) | 40.48% |
| Years of Dividend Growth | 11 |
| Payout Ratio | 55.12% |
| Buyback Yield | 32.28% |
| Shareholder Yield | 34.46% |
| Earnings Yield | 3.82% |
| FCF Yield | 4.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 22, 2023. It was a forward split with a ratio of 1.04.
| Last Split Date | May 22, 2023 |
| Split Type | Forward |
| Split Ratio | 1.04 |
Scores
Raia Drogasil has an Altman Z-Score of 3.87 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.87 |
| Piotroski F-Score | 5 |